(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.54%) $78.90
(-1.00%) $2.17
(0.16%) $2 334.90
(0.31%) $27.70
(0.15%) $966.30
(0.01%) $0.928
(0.05%) $10.83
(0.02%) $0.796
(-0.01%) $91.34
0.61% ¥ 495.00
Live Chart Being Loaded With Signals
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas...
Stats | |
---|---|
Tagesvolumen | 14 600.00 |
Durchschnittsvolumen | 69 389.00 |
Marktkapitalisierung | 19.59B |
EPS | ¥0 ( 2024-04-12 ) |
Nächstes Ertragsdatum | ( ¥0 ) 2024-07-10 |
Last Dividend | ¥9.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.06 |
ATR14 | ¥0.518 (0.11%) |
Astena Holdings Co., Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Astena Holdings Co., Ltd. Finanzdaten
Annual | 2023 |
Umsatz: | ¥51.98B |
Bruttogewinn: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2023 |
Umsatz: | ¥51.98B |
Bruttogewinn: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2022 |
Umsatz: | ¥49.64B |
Bruttogewinn: | ¥15.44B (31.11 %) |
EPS: | ¥14.56 |
FY | 2021 |
Umsatz: | ¥72.32B |
Bruttogewinn: | ¥16.60B (22.96 %) |
EPS: | ¥46.86 |
Financial Reports:
No articles found.
Astena Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.75 | 2001-05-28 |
Last Dividend | ¥9.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | ¥149.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 9.60 | |
Div.Growth Potential Score | 3.35 | |
Div. Directional Score | 6.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8011.T | Ex Dividend Junior | 2024-02-28 | Sporadic | 0 | 0.00% | |
7250.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6486.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5703.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4523.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3681.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2975.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
1827.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9404.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8345.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0306 | 1.500 | 9.39 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0245 | 1.200 | 9.18 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0583 | 1.500 | -0.463 | -0.695 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.262 | 0.800 | 8.69 | 6.95 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.162 | 1.500 | -0.210 | -0.315 | [0.2 - 2] |
debtRatioTTM | 0.236 | -1.500 | 6.06 | -9.09 | [0 - 0.6] |
interestCoverageTTM | 22.43 | 1.000 | 2.81 | 2.81 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.546 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.323 | 1.000 | 7.95 | 7.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.364 | -1.364 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.226 | 1.000 | 9.86 | 9.86 | [0.2 - 2] |
assetTurnoverTTM | 0.798 | 0.800 | 8.01 | 6.41 | [0.5 - 2] |
Total Score | 9.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.05 | 1.000 | 8.88 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0583 | 2.50 | -0.298 | -0.695 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.66 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.118 | 1.500 | -2.55 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0669 | 1.000 | -0.826 | 0 | [0.1 - 0.5] |
Total Score | 3.35 |
Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.